The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.
Drug-induced liver injury
Open accessAbstract
Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The vast majority of cases of DILI occur at therapeutic doses in a small proportion of individuals exposed to the drug, representing an idiosyncratic reaction, and therefore unpredictable based on the drug's mechanism of action and related to the uniqueness of the individual [1,2].”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [1]
In the citing paper
“Drug-induced liver injury (DILI) is an uncommon adverse reaction to drugs, and other chemicals, including herbal and dietary supplements (HDS).”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1128/aac.04976-14 · retracted 2015-12-28 · notice 10.1128/aac.04976-14 · this paper published 2019-08-22
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Francis, B. et al. Temporary removal: reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers. J. Hepatol. https://doi.org/10.1016/j.jhep.2018.04.024 (2018).”
Cited work 10.1016/j.jhep.2018.04.024 · retracted 2018-05-03 · notice 10.1016/j.jhep.2018.04.024 · this paper published 2019-08-22
Citations
Cites
2 retracted
Francis, B., Clarke, J. I., Walker, L. E., Brillant, N., Jorgensen, A., Park, B. K., Pirmohamed, M., & Antoine, D. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.04.024 · Cited by 4
RetractedAhrens, J. H., & Sastic, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04976-14 · Cited by 3
Retracted(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M. L., Reindollar, R., Goodman, Z. D., Koury, K. J., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,027
Research works printed but not linked: 3
- Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
- Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
- Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).
Cited by
Sorted by citations
Items 201–300 of 922
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 21
Zhan, X., Wang, F., & Gevaert, O. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3193365 · Cited by 21
Wang, K., Zhang, L., Li, L., Wang, Y., Zhong, X., Hou, C., Zhang, Y., Sun, C., Zhou, Q., & Wang, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911945 · Cited by 21
Song, X., Li, M., Ni, S., Yang, K., Li, S., Li, R., Zheng, W., Tu, D., Chen, X., & Yang, H. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04849 · Cited by 21
Wang, S., Zhang, L., Luo, Y., Bai, Y., Huang, Y. X., & Zhao, S. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04237 · Cited by 21
Chen, J., Wu, H., Tang, X.-D., & Chen, L. (2022) · Bioengineered · doi:10.1080/21655979.2021.2024970 · Cited by 21
Zhuo, Y., Zhang, Y., Li, M., Wu, H., Gong, S., Hu, X., Fu, Y., Shen, X., Sun, B., Wu, J., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112257 · Cited by 20
Wang, S., Bao, J., Bao, J., Li, J., Tian, M., Qiu, C., Pang, F., Li, X., Yang, J., Hu, Y., et al. (2022) · Molecules · doi:10.3390/molecules27092647 · Cited by 20
Li, Y., Zhang, J., Cheng, S., Wang, X., Zhang, J., Xie, X., Jiao, X., & Tang, B. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03540 · Cited by 20
Mao, B., Ren, B., Wu, J., Tang, X., Zhang, Q., Zhao, J., Zhang, L., Chen, W., & Cui, S. (2023) · Foods · doi:10.3390/foods12142786 · Cited by 20
Ye, X., Wu, Z., Chen, Y., Mu, W., Zhao, X., Dong, M., Li, Y., Bai, Z., & Xiao, X. (2024) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000115 · Cited by 20
Li, C., Hu, Y., Nie, Q., Chen, S., Li, G., Li, L., Chen, S., Tang, B., & Zhang, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01660h · Cited by 20
Villa-Jaimes, G. S., Moshage, H. J., Avelar-González, F. J., González-Ponce, H. A., Buist‐Homan, M., Guevara‐Lara, F., Sánchez‐Alemán, E., Martínez-Hernández, S. L., Ventura‐Juárez, J., Muñoz‐Ortega, M. H., et al. (2023) · Antioxidants · doi:10.3390/antiox12010113 · Cited by 20
Bioprinted high cell density liver model with improved hepatic metabolic functions
Lu, T.-Y., Ji, Y., Lyu, C., Shen, E. N., Sun, Y., Xiang, Y., Meng‐Saccoccio, T., Feng, G., & Chen, S. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123256 · Cited by 19
Lee, T., & Posma, J. M. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01068-3 · Cited by 19
Therapeutic potential of plant-derived natural products against drug-induced liver injury
Chen, Y., Mei, Y., Hou, L., & Li, K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1652860 · Cited by 19
Targeting ferroptosis as a therapeutic strategy for hepatotoxicity
Hemmati, N., Anoush, M., Kiasari, B. A., & Torkamani, A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102137 · Cited by 19
Wurm, K. W., Bartz, F., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2022) · ChemMedChem · doi:10.1002/cmdc.202200262 · Cited by 19
Dong, J., Yang, Y., Fan, X., Zhu, H., & Li, Z. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100689 · Cited by 19
Sweilam, S. H., Ali, D. E., Atwa, A. M., Elgindy, A. M., Mustafa, A. M., Esmail, M. M., Alkabbani, M. A., Senna, M. M., & El‐Shiekh, R. A. (2024) · Pharmaceuticals · doi:10.3390/ph17070970 · Cited by 19
Yu, S., Li, J., He, T., Zheng, H., Wang, S., Sun, Y., Wang, L., Jing, J., & Wang, R. (2024) · Hepatology International · doi:10.1007/s12072-024-10679-1 · Cited by 18
Mao, Y., Zhang, W., Wang, X., Li, P., & Tang, B. (2026) · Chemical Society Reviews · doi:10.1039/d5cs00947b · Cited by 18
Wang, Y., Ma, R., Zou, B., Li, J., Yao, Y., & Li, J. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105534 · Cited by 18
Zheng, J., Yang, N., Wan, Y., Cheng, W., Zhang, G., Yu, S., Yang, B., Liu, X., Chen, X., Ding, X., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02321-8 · Cited by 18
Radloff, K., Gutbier, B., Dunne, C. M., Moradian, H., Schwestka, M., Gossen, M., Ahrens, K., Kneller, L., Wang, Y., Moga, A., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102068 · Cited by 18
Wang, H., Liu, J., Peng, Z., Wang, Q., Wei, J., & Li, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.3c02346 · Cited by 18
Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury
Niu, H., Álvarez‐Álvarez, I., & Chen, M. (2025) · Liver International · doi:10.1111/liv.70038 · Cited by 18
Zheng, J., Zhou, H., Yang, T., Liu, J., Qin, T., Gu, X., Wu, J., Zhang, Y., Wang, H., Tang, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.011 · Cited by 18
Vazquez, J. H., & McGill, M. R. (2021) · Livers · doi:10.3390/livers1040022 · Cited by 18
Liver involvement in inflammatory bowel disease: What should the clinician know?
Losurdo, G., Brescia, I. V., Lillo, C., Mezzapesa, M., Barone, M., Principi, M., Ierardi, E., Leo, A. D., & Rendina, M. G. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1534 · Cited by 18
Liu, X., Long, J., Luo, H., Xiang, M., Qi, F.-Y., Peng, L., Zheng, G., Jiang, J., & Zhang, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03077 · Cited by 17
Safety of treating acute liver injury and failure
García‐Cortés, M., Ortega‐Alonso, A., & Andrade, R. J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1955854 · Cited by 17
Self-citationPolydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
Carmignani, A., Battaglini, M., Bartolucci, M., Petretto, A., Prato, M., & Ciofani, G. (2024) · Materials & Design · doi:10.1016/j.matdes.2024.112825 · Cited by 17
Wang, Q.-Q., Wu, S.-P., Yang, J.-H., Li, J., Sun, X.-Y., Yang, T., & Mao, G. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.110288 · Cited by 17
The roles and potential mechanisms of plant polysaccharides in liver diseases: a review
Wei, X., Luo, D., Li, H., Li, Y., Cen, S., Huang, M., Jiang, X., Zhong, G., & Zeng, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1400958 · Cited by 17
Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
Eadie, L., Lo, L. A., Boivin, M. R., Deol, J. K., & MacCallum, C. A. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16730 · Cited by 17
Nanoprobes based on optical imaging techniques for detecting biomarkers in liver injury diseases
Sun, Y., Wang, J., Zhu, Y., Han, T., Liu, Y., & Wang, H.-Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216303 · Cited by 17
Guan, J., Dong, D., Xie, P., Zhao, Z., Guo, Y., Lee, T.-Y., Yao, L., & Chiang, Y. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02079 · Cited by 17
New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury
Ezquer, F. E., Huang, Y.-L., & Ezquer, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052669 · Cited by 17
Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator
Weinblatt, D., & Roy, S. (2022) · Journal of Medical Cases · doi:10.14740/jmc3937 · Cited by 17
Ahmed, H. M., Shehata, H. H., El-Saeed, G. S. M., Gabal, H. H. A., & El‐Daly, S. M. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00422-4 · Cited by 17
Grossini, E., Pour, M. M. O., & Venkatesan, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115033 · Cited by 17
You, Y., Guan, X., Zhao, H., Wu, T., Wang, C., Xiao, Y., Zhou, Y., Hong, S., Fu, Y., He, M., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.127059 · Cited by 16
Bai, Z., Tao, W., Zhou, Y., Cao, Y., Yu, S., & Shi, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.948128 · Cited by 16
Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
Li, X., Wang, W. “., Yan, S., Zhao, W., Xiong, H., Bao, C., Chen, J., Yue, Y., Su, Y., & Zhang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1019487 · Cited by 16
Liang, H., Yan, Z., Tong, Y., Chen, S., Li, J., Chen, L., & Yang, H. (2023) · Chemical Communications · doi:10.1039/d2cc06176g · Cited by 16
Therapeutic interventions of acute and chronic liver disorders: A comprehensive review
Ali, F. E. M., El‐Aziz, M. K. A., Sharab, E. I., & Bakr, A. G. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i1.19 · Cited by 16
Iron oxide nanoparticles trigger endoplasmic reticulum damage in steatotic hepatic cells
Uzhytchak, M., Lunová, M., Smolková, B., Jirsa, M., Dejneka, A., & Lunov, O. (2023) · Nanoscale Advances · doi:10.1039/d3na00071k · Cited by 16
Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination
Tak, J., & Kim, S. G. (2023) · Toxicological Research · doi:10.1007/s43188-023-00201-4 · Cited by 16
Liu, Y., Wang, X., Fu, N., & Wang, G. (2024) · Dyes and Pigments · doi:10.1016/j.dyepig.2024.112102 · Cited by 16
Xing, R., Liu, R., Man, Y., Liu, C., Zhang, Y., Gao, H., & Yang, W. (2025) · Cell Discovery · doi:10.1038/s41421-024-00758-w · Cited by 16
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
Stephens, C. M., Lucena, M. I., & Andrade, R. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00253 · Cited by 16
Self-citationExtracellular vesicles: Roles and applications in drug-induced liver injury
Umbaugh, D. S., & Jaeschke, H. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.08.010 · Cited by 16
Tu, C., Niu, M., Wei, A.-W., Tang, J.-F., Zhang, L., Jing, J., Xiao, X.-H., & Wang, J.-B. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299892 · Cited by 15
An Approach to Drug-Induced Liver Injury from the Geriatric Perspective
Lee, B. T., Odin, J. A., & Grewal, P. (2021) · Current Gastroenterology Reports · doi:10.1007/s11894-021-00804-7 · Cited by 16
Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactions
Kuula, L. S. M., Backman, J. T., & Blom, M. L. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.931 · Cited by 16
Hoven, M., de Boer, N. S., Goudriaan, A. E., Denys, D. A. J. P., Lebreton, M. P., van Holst, R. J., & Luigjes, J. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13434 · Cited by 16
Methods for causality assessment of idiosyncratic drug‐induced liver injury
García‐Cortés, M., Matilla‐Cabello, G., & Lucena, M. I. (2025) · Liver International · doi:10.1111/liv.16083 · Cited by 15
Self-citationProgress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice
von Samson‐Himmelstjerna, F. A., Kolbrink, B., Riebeling, T., Kunzendorf, U., & Krautwald, S. (2022) · Cells · doi:10.3390/cells11142134 · Cited by 15
Hu, Y., Wang, C., Fei, Z.-Y., Zhou, M., Yu, H. N., & Sun, Z. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116217 · Cited by 15
Deng, Y.-L., Lu, T., Hao, H., Liu, C., Yuan, X.-Q., Yu, M., Zhang, M., Zeng, J.-Y., Li, Y., Lu, W., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp13386 · Cited by 15
Drug reactive metabolite-induced hepatotoxicity: a comprehensive review
Mahajan, P., Palkar, M. B., & Pingili, R. B. (2024) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2024.2332613 · Cited by 15
Ding, Z., Wang, X., Zhang, Y., Liu, J., Wan, L., Li, T., Chen, L., Lin, N., & Zhang, Y. (2024) · Engineering · doi:10.1016/j.eng.2024.04.003 · Cited by 15
Roles of X-box binding protein 1 in liver pathogenesis
Tak, J., Kim, Y. S., & Kim, S. G. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0441 · Cited by 15
Su, Y., Zeng, Y., Zhou, M., Liao, M., Qin, P., Wu, R., Han, J., Liang, X., Wang, Z., Jiang, J., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0167 · Cited by 15
Multiscale modeling of drug-induced liver injury from organ to lobule
Malka-Markovitz, A., Pinto, S. C. D., Cherkaoui, M., Levine, S. M., Anandasabapathy, S., Sood, G., Dhingra, S., Yujia, G., Vierling, J. M., & Gallo, N. R. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01736-6 · Cited by 15
Liu, T., Tian, M., Wang, J., Tian, X., Liu, J., Feng, L., Ma, X., & Cui, J. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.119362 · Cited by 15
Rodríguez, A., García-García, I., de Soto, L. M., Huertas, A. G. L. D. L., Borobia, A. M., González‐Torbay, A., Akatbach-Bousaid, I., González‐Muñoz, M., & Ramı́rez, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819589 · Cited by 15
McAtee, C. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.04.007 · Cited by 15
Drug-induced liver injury: An overview and update
Wang, Y., & Xie, W. (2023) · Gastroenterology & Endoscopy · doi:10.1016/j.gande.2022.11.005 · Cited by 15
Huang, Y.-L., Gregorio, C. D., Silva, V., Elorza, Á. A., Léniz, P., Aliaga-Tobar, V., Maracaja‐Coutinho, V., Budini, M., Ezquer, F. E., & Ezquer, M. (2023) · Cells · doi:10.3390/cells12040636 · Cited by 15
A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin
Shen, P., Bai, Z., Zhou, L., Wang, N., Ni, Z., Sun, D., Huang, C., Hu, Y.-Y., Xiao, C., Zhou, W., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.03.010 · Cited by 14
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Pinazo-Bandera, J. M., Toro-Ortiz, J. P., Andrade, R. J., & García‐Cortés, M. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00027 · Cited by 14
Self-citationAnti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin Materials
Li, L., Chen, B., Li, G., Chen, S., & Zhang, J. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300106 · Cited by 14
S-nitrosylation attenuates pregnane X receptor hyperactivity and acetaminophen-induced liver injury
Cui, Q., Jiang, T., Xie, X., Wang, H., Lei, Q., Cheng, Y., Li, Q., Lu, T., Yao, Q., Liu, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.172632 · Cited by 14
Arshad, M., Kousar, S., Din, A., Afzaal, M., Faisal, M. N., Sharif, M. K., Rasheed, H., Saeed, F., Akram, N., Ahmed, F., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4149 · Cited by 14
Qiu, J., Chen, L., Ren, G. R., Xu, F., Hu, T., Le, Y., Fan, X., Yu, Z., Liu, Q., Wang, X., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155799 · Cited by 14
Román-Sagüillo, S., Castro, R. Q., Juárez‐Fernández, M., Soluyanova, P., Stephens, C. M., Robles‐Díaz, M., Jorquera, F., González‐Gallego, J., Martínez‐Flórez, S., García‐Mediavilla, M. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136863 · Cited by 14
Martini, T., Gobet, C., Salati, A., Blanc, J., Mookhoek, A., Reinehr, M. D., Knott, G. W., Sordet‐Dessimoz, J., & Naef, F. (2024) · Nature Communications · doi:10.1038/s41467-024-52751-2 · Cited by 14
Cui, Z., Wang, Y., Wang, G., Feng, B., Lewis, S. E., Wang, K., Jiang, K., James, T. D., & Zhang, H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04926 · Cited by 14
Amin, S. A., Kar, S., & Piotto, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c00075 · Cited by 14
Management of drug-induced liver injury associated with anti-cancer therapy
Vincenzi, B., Yimin, M., Andrade, R. J., Castillo, M. M., Akhundova‐Unadkat, G., & Mato, J. M. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1541020 · Cited by 14
Self-citationLiu, Y., Li, Q., Zheng, Z., Zhang, J., & Feng, G. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137948 · Cited by 14
Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models
Devarbhavi, H. C., & Andrade, R. J. (2025) · Liver International · doi:10.1111/liv.70138 · Cited by 14
Self-citationTu, C., Gao, Y. J., Song, D., Niu, M., Ma, R.-R., Zhou, M., He, X., Xiao, X., & Wang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.693928 · Cited by 14
ADENet: a novel network-based inference method for prediction of drug adverse events
Yu, Z., Wu, Z., Li, W., Liu, G., & Tang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab580 · Cited by 14
Wang, X., Zhao, J., Zhang, R., Liu, X., Ma, C., Cao, G., Wei, Y., & Yang, P. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s358498 · Cited by 14
Ghanem, C. I., & Manautou, J. E. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000450 · Cited by 14
Engineering of Biodegradable and Excretable Inflammation‐Resolving Materials
Wu, P., Gao, M., Zhang, C., Li, C., Li, G., Yan, X., Lai, X., Zhang, Y., & Zhang, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205528 · Cited by 14
Recreational Drugs and the Risk of Hepatocellular Carcinoma
Pinazo-Bandera, J. M., García‐Cortés, M., Segovia‐Zafra, A., Lucena, M. I., & Andrade, R. J. (2022) · Cancers · doi:10.3390/cancers14215395 · Cited by 14
Self-citationRed-fleshed apple flavonoid extract alleviates CCl4-induced liver injury in mice
Chen, Y., Wang, Y., Jiang, S., Xu, J., Wang, B., Sun, X., & Zhang, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1098954 · Cited by 14
Isoliquiritigenin ameliorates paroxetine-induced sexual dysfunction in male albino mice
Saikia, Q., Hazarika, A., & Kalita, J. C. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108341 · Cited by 14
do Nascimento, M. F., Costa, W. K., de Aguiar, J. C. R. D. O. F., Navarro, D. M. D. A. F., da Silva, M. V., Paiva, P. M. G., de Oliveira, A. M., & Napoleão, T. H. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116908 · Cited by 14
Wang, H., Xu, J.-S., Zong, K., Liang, Z., Li, R., Xue, J.-F., Ding, J., & Zhao, L. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115810 · Cited by 14
Wang, Y., She, S., Li, W., Zhu, J., Li, X., Yang, F., & Dai, K. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.12.005 · Cited by 14
Jiang, T., Guo, H., Xia, Y., Liu, Y., Chen, D., Pang, G., Feng, Y., Yu, H., Wu, Y., Zhang, S., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0011 · Cited by 14
Brugger, M., Laschinger, M., Lampl, S., Schneider, A., Manske, K., Esfandyari, D., Hüser, N., Hartmann, D., Steiger, K., Engelhardt, S. H., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100465 · Cited by 14
Niu, H., Solís‐Muñoz, P., García‐Cortés, M., Sanabria‐Cabrera, J., Robles‐Díaz, M., Romero-Flores, R., Bonilla‐Toyos, E., Ortega‐Alonso, A., Pinazo-Bandera, J. M., Cabello, M. R., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107030 · Cited by 13
Self-citationQin, P., Li, Y., Su, Y., Wang, Z., Wu, R., Liang, X., Zeng, Y., Guo, P., Yu, Z., Huang, X., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05312-6 · Cited by 13
Fu, H., Zhao, S., Song, S., & Xie, Q. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1432049 · Cited by 13
Metadata
- Authors
- Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
- Affiliations
- Indiana University School of Medicine (US)
- Duke University (US)
- Novartis (Switzerland) (CH)
- University of North Carolina at Chapel Hill (US)
- St.John's Medical College Hospital (IN)
- University of Zurich (CH)
- Spanish Clinical Research Network (ES)
- Nottingham University Hospitals NHS Trust (GB)
- Corresponding author
- Lucena, M. Isabel
- ORCID
- Venue
- Nature Reviews Disease Primers
- Published
- 2019-08-22
- Volume
- 5
- Issue
- 1
- Pages
- 58-58
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W1565605888
- Cited by
- 924
- References
- 982
- Citations by year
- 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
- MeSH terms
- Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
